Medical Breakthroughs Reported by Click here to go to the homepage.
Be the First to Know. Click here to subscribe FREE!
Search Reports: Use quotation marks around your multi-word search terms in the box below to perform search of
Advances in health and medicine.Use " marks around search terms
What's New
News Flash
  Alternative Health
Asthma & Allergies
Breast Cancer
Cardiovascular Health
Children's Health
Dental Health
Fertility & Pregnancy
Men's Health
Mental Health
Multiple Sclerosis
Neurological Disorders
Nutrition & Wellness
Pet Health
Seniors' Health
Sports Medicine
Women's Health
Advances in health and medicine.
Click here to sign up for Medical Alerts!
Click below to access other news from Ivanhoe Broadcast News.
  Click here to get Ivanhoe's Medical Headline RSS feed Click here to listen to Ivanhoe's Medical Podcasts
Useful Links
Play It Again, Please
E-Mail a Friend
Order Books Online
Inside Science
Smart Woman
Advances in health and medicine.
Smart Woman Home
Click here to read the story
Click here to read the story
Click here to read the story
Smart Woman Home
Advances in health and medicine.
Click below to learn about Ivanhoe.
About Us
Contact Us
Ivanhoe FAQ
Our TV Partners
Travel Calendar
Advances in health and medicine.
Ivanhoe celebrates 20 years of medical news reporting reaching nearly 80 million TV households each week. Click here to learn more...
Advances in health and medicine.
Marjorie Bekaert Thomas
Advances in health and medicine.
Cardiovascular Health Channel
Reported March 4, 2013

Bad Meds for Heart Failure

(Ivanhoe Newswire) -- Heart failure, where the heart is not able to pump enough blood to meet the body’s needs, can be a very serious condition but luckily it is also treatable. Several different medications used to treat heart failure are available, though patients may want to avoid the drug spironolactone. According to a new German study, long-term treatment with spironolactone does not improve symptoms or quality of life for heart failure patients.

Between March 2007 and April 2012, researchers studied 422 patients with chronic New York Heart Association class II or III heart failure, preserved left ventricular ejection fraction of 50% or greater, and evidence of diastolic dysfunction. The patients were given either 25mg of spironolactone or a placebo each day and also had twelve months of follow up.

In this study, researchers focused on heart failure patients with preserved ejection fraction, the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat, of 50% or higher because they make up 50% of all HF patients.

Although spironolactone did increase left ventricular diastolic function, the drug made no difference in the patients’ quality of life or heart failure symptoms compared to the placebo. Spironolactone also did not improve maximal exercise capacity and even reduced participants’ six minute walking distance.

Further studies testing the effectiveness of spironolactone for treating heart failure should be done to confirm these results, but for now people may want to opt for a different medication.

SOURCE: JAMA, February 2013

Want to be the FIRST TO KNOW?

Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.

Related Articles in Latest Medical News:

[ Back to Cardiovascular Health Channel Home ]

Stay up to date on Cardiovascular Health. We can notify you every time there is a medical breakthrough. Click here to sign up.
Most Recent Videos

Follow Us On:

Click here to go to Ivanhoe's Twitter page Click here to go to Ivanhoe's Facebook page Click here to go to Ivanhoe's YouTube page

Home | What's New | News Flash | Search/Latest Medical News | E-Mail Medical Alerts!
Ivanhoe FAQ | Privacy Policy | Our TV Partners | Awards | Useful Links | Play It Again, Please
RSS Feeds | Advertising/Sponsorships | Content Syndication | Reprints

Advances in health and medicine.
Copyright © 2016 Ivanhoe Broadcast News, Inc.
2745 West Fairbanks Avenue
Winter Park, Florida 32789
(407) 740-0789

P.O. Box 865
Orlando, Florida 32802

Premium Content in Latest Medical News Denotes Premium Content in Latest Medical News